Clinical Trial Detail

NCT ID NCT03973879
Title Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Darell D. Bigner, MD, PhD
Indications

malignant glioma

Therapies

Atezolizumab + PVSRIPO

Age Groups: adult senior

No variant requirements are available.